Results 261 to 270 of about 965,485 (298)

Foreign Contaminants Target Brain Health

CNS & Neurological Disorders - Drug Targets
Neurodisease, caused by undesired substances, can lead to mental health conditions like depression, anxiety and neurocognitive problems like dementia. These substances can be referred to as contaminants that can cause damage, corruption, and infection or reduce brain functionality.
Uma Agarwal, Arzoo Pannu, Rajiv Kumar Tonk   +2 more
openaire   +2 more sources

Targeting the Brain with Nanomedicine

Current Pharmaceutical Design, 2017
Herein, we review innovative nanomedicine-based approaches for treating, preventing and diagnosing neurodegenerative diseases. We focus on nanoscale systems such as polymeric nanoparticles (NPs), liposomes, micelles and other vehicles (e.g. dendrimers, nanogels, nanoemulsions and nanosuspensions) for targeted delivery of bioactive molecules to the ...
Rueda, F., Cruz, L.J.
openaire   +3 more sources

Targeted Therapies for Brain Metastases

2019
The most common primary cancers that metastasize to the brain are lung cancer, breast cancer, and melanoma. The established management approaches for brain metastasis include stereotactic radiosurgery, fractionated radiation therapy, and surgical resection. In the past the role of medical therapies in brain metastases was limited.
Ajay, Niranjan, L Dade, Lunsford, Manmeet S, Ahluwalia   +2 more
openaire   +2 more sources

Nanotechnology in Brain Targeting

International Journal of Pharmaceutical Sciences and Nanotechnology, 1970
Nanotechnology offers a vision for a ‘smart’ drug approach involving the design, synthesis, and characterization of materials and devices that have a functional association in nanometer scale. One area in which nanotechnology may have a significant clinical impact in neuroscience is the selective transport and delivery of drugs and other small ...
Hamsaraj Karanth, Ramachandra Murthy Rayasa S.   +1 more
openaire   +1 more source

Targeted Therapy for Brain Metastases

2012
The prevention and treatment of brain metastases is an increasingly important challenge in oncology. Improved understanding of the molecular pathogenesis of a number of cancers has led to the development of highly active targeted therapies for patients with specific oncogenic events.
openaire   +2 more sources

Brain Targeting in MPS-IIIA.

Pediatric endocrinology reviews : PER, 2016
Mucopolysaccharidosis type IIIA (MPS-IIIA) is a childhood metabolic neuropathology caused by the inherited deficiency of the lysosomal enzyme sulfamidase and is characterized by the accumulation of undegraded glycosaminoglycans in the lysosomes of cells and tissues of affected patients.
Sorrentino, Nicolina Cristina, FRALDI, ALESSANDRO   +1 more
openaire   +2 more sources

Metabolic target for brain metastasis

Nature Reviews Drug Discovery, 2021
openaire   +2 more sources

Brain and other central nervous system tumor statistics, 2021

Ca-A Cancer Journal for Clinicians, 2021
Kimberly D Miller, Quinn T Ostrom, Carol Kruchko Ba   +2 more
exaly  

An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma

Ca-A Cancer Journal for Clinicians, 2022
Elshad Hasanov, Marion Smits, Shaan Dudani   +2 more
exaly  

Brain-Targeted Delivery of Estrogens

Reviews in the Neurosciences, 1990
M E, Brewster, J W, Simpkins, N, Bodor
openaire   +2 more sources